Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
Abstract Introduction The association between omeprazole and hypertension is poorly documented. The summary of product characteristics of omeprazole approved by major regulators did not mention hypertension as an adverse drug event. Triggered by a locally reported case, this study was conducted to a...
Saved in:
Main Authors: | Merhawi Bahta (Author), Natnael Russom (Author), Amon Solomon Ghebrenegus (Author), Yohana Tecleab Okubamichael (Author), Mulugeta Russom (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
by: Merhawi Bahta, et al.
Published: (2024) -
Tamsulosin and risk of priapism: A causality assessment using Austin Bradford Hill Criteria
by: Mulugeta Russom, et al.
Published: (2022) -
Praziquantel and risk of visual disorders: Case series assessment.
by: Merhawi Debesai, et al.
Published: (2020) -
Household Pharmaceutical Disposal Practices, Community Understanding, and Readiness for Medicines Take-Back in Asmara, Eritrea: A Cross-Sectional Analysis
by: Habte HY, et al.
Published: (2024) -
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
by: Marion Allouchery, et al.
Published: (2021)